La vendita allo scoperto per Pitney Bowes dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Pitney Bowes. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Pitney Bowes (NYSE:PBI) Azioni, Report sulle vendite allo scoperto

Pitney Bowes

Pitney Bowes is a Global technology company that offers e-commerce solutions to its clients. The company provides various products and services such as domestic delivery, return and fulfillment, cross-border shipping solutions, sorting services for large volumes of postal mails, technological solutions to enable digital mailing, shipping, and other services. The company operates through three business segments: Global e-commerce, presort services, and SendTech Solutions. The company generates majority of its revenue from United States.

Pitney Bowes Inc

PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd

PT BFI FNCE INDNSIA TBK by Pt BFI Finance Indonesia Tbk

PT BFI Finance Indonesia Tbk

Bioxyne Ltd

PRESSURE BIOSCIENCES by Pressure BioSciences, Inc.

Pressure BioSciences Inc

PITNEY BOWES ORD

Pitney Bowes Inc 6.70% Notes Due 2043

New solution leverages extensive history of innovation to better serve growing ecommerce market
Pitney Bowes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>), a global shipping and mailing company, today announced the launch of ShipAccel, a digital platform designed to simplify and enhance shipping operations with advanced ecommerce technology. This launch reinforces Pitney Bowes' offerings in the ecommerce market, now aimed at equipping shippers with technology that addresses their evolving needs.

News

Pitney Bowes Enhances Ecommerce Shipping With ShipAccel, Leveraging History Of Innovation To Better Serve Growing Ecommerce Market

WIIM

Pitney Bowes shares are trading higher after the company reported better-than-expected Q2 financial results.

Pitney Bowes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.07) by 142.86 percent. The company reported quarterly sales of $793.170 million which beat the analyst consensus estimate of $771.648 million by 2.79 percent. This is a 2.15 percent increase over sales of $776.481 million the same period last year.

Earnings

Earnings Beats

Pitney Bowes Q2 2024 Adj. EPS $0.03 Beats $(0.07) Estimate, Sales $793.170M Beat $771.648M Estimate

Asset Sales

Pitney Bowes Still Working To Conclude Its Strategic Review Of Company's Global e-commerce Segment; Has Sold Segment's Fulfillment Services Business, Which Is A Small Piece Of Global e-commerce Segment

General

Pitney Bowes shares are trading higher following a report indicating that the company has sold a part of its e-commerce business to Stord.

Shares of Pitney Bowes Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) shares rose sharply in today's pre-market trading following a report indicating that the company has sold a part of its <a href="https://www.benzinga.com/quote/PBI/news">e-commerce business to Stord</a>.
Pitney Bowes shares jumped 12.5% to $7.58 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Cognition Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) gained 46% to $3.45 in pre-market trading after the company announced that it will host an investor presentation to discuss results from its phase 2 SHINE study of CT1812 on Monday July 29, 2024.</li>
<li>Longeveron Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) shares climbed 36.3% to $4.69 in pre-market trading after the company disclosed study results from CLEAR MIND Phase 2a clinical trial of Lomecel-B in mild Alzheimer&#8217;s disease.</li>
<li>Planet Image International Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YIBO#NASDAQ">YIBO</a>) rose 35.7% to $3.99 in pre-market trading after jumping around 56% on Friday.</li>
<li>DDC Enterprise Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDC#NYSE">DDC</a>) shares gained 22.7% to $0.76 in pre-market trading after gaining 6% on Friday.</li>
<li>BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) gained 22.1% to $0.5133 in pre-market trading. BurgerFi shares jumped 97% on Friday after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.</li>
<li>Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares gained 19.4% to $0.5395 in pre-market trading after gaining 11% on Friday.</li>
<li>Ambipar Emergency Response (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBI#NYSE">AMBI</a>) gained 15.5% to $5.34 in pre-market trading after jumping 29% on Friday.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares gained 14.1% to $0.3371 in pre-market trading. TransCode Therapeutics 13G filing showed 3i, LP reported a 9.9% stake in the company, as of July 23.</li>
<li>Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) gained 11.4% to $7.51 in pre-market trading. Anavex Life Sciences presented comprehensive results from the Phase IIb/III study showing that blarcamesine, once daily orally, significantly slowed clinical decline in people with early Alzheimer&#8217;s disease.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>vTv Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTVT#NASDAQ">VTVT</a>) shares fell 37.4% to $13.28 in pre-market trading after the company announced the FDA has placed a clinical hold on the cadisegliatin clinical program which includes the ongoing CATT1 phase 3 trial in type 1 diabetes.</li>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) shares declined 34% to $0.1690 in pre-market trading after gaining 6% on Friday.</li>
<li>LuxUrban Hotels Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUXH#NASDAQ">LUXH</a>) shares fell 22.1% to $0.1488 in pre-market trading after the company priced its $1.74 million public offering of 11,573,333 common shares at 15 cents per share.</li>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) shares fell 19.6% to $1.48 in pre-market trading.</li>
<li>Globavend Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) shares declined 13.1% to $0.63 in pre-market trading after surging 24% on Friday.</li>
<li>Phio Pharmaceuticals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) fell 12.6% to $3.53 in pre-market trading. Phio Pharmaceuticals recently announced exercise of warrants for $3.1 million gross proceeds.</li>
<li>INVO Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) shares fell 11.6% to $0.7250 in pre-market trading after jumping 11% on Friday.</li>
<li>NuZee Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUZE#NASDAQ">NUZE</a>) fell 9.7% to $3.40 in pre-market trading after surging around 25% on Friday.</li>
<li>EZCORP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) shares dipped 8.8% to $9.41 in pre-market trading.</li>
<li>Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) shares fell 6.6% to $98.29 in pre-market trading. A jury ordered Abbott to pay $495 million in compensation and damages in a baby-formula verdict, the Wall Street Journal reported.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984123/jim-cramer-is-mystified-by-five-below-predicts-crowdstrike-is-going-to-bottom-here">Jim Cramer Is &#8216;Mystified&#8217; By Five Below, Predicts CrowdStrike &#8216;Is Going To Bottom Here</a><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984123/jim-cramer-is-mystified-by-five-below-predicts-crowdstrike-is-going-to-bottom-here">&#8216;</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

AMBI

AVXL

CERO

CGTX

EZPW

INVO

LGVN

LUXH

NUZE

PHIO

RNAZ

TIVC

VTVT

YIBO

Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) to report quarterly earnings at $3.07 per share on revenue of $6.61 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. McDonald&#8217;s shares fell 0.3% to $251.18 in after-hours trading.</li>
<li>Nasdaq, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) reported a secondary offering of 41,604,207 shares of common stock. Nasdaq shares fell 2.6% to $65.25 in the after-hours trading session.</li>
<li>Analysts are expecting ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) to post quarterly earnings at 92 cents per share on revenue of $1.73 billion. The company will release earnings before the markets open. ON Semiconductor shares rose 1.2% to $70.98 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Pitney Bowes Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) shares moved higher during Friday's after-hours trading following a report indicating that the company has sold a part of its e-commerce business to Stord. Pitney Bowes shares jumped 12.6% to $7.59 in the after-hours trading session.</li>
<li>Analysts expect Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) to post quarterly earnings at 78 cents per share on revenue of $1.83 billion after the closing bell. Sprouts Farmers Market shares gained 1% to $87.55 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39984491/nvidia-lockheed-martin-and-2-other-stocks-insiders-are-selling">Nvidia, Lockheed Martin And 2 Other Stocks Insiders Are Selling</a></li>
</ul>
Photo courtesy: Shutterstock

NDAQ

McDonald's, ON Semiconductor And 3 Stocks To Watch Heading Into Monday

<a href="https://www.theinformation.com/articles/logistics-startup-stord-buys-part-of-pitney-bowes-e-commerce-business" title="https://www.theinformation.com/articles/logistics-startup-stord-buys-part-of-pitney-bowes-e-commerce-business">https://www.theinformation.com/articles/logistics-startup-stord-buys-part-of-pitney-bowes-e-commerce-business</a>

'Logistics Startup Stord Buys Part of Pitney Bowes' E-Commerce Business' - The Information

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Industrials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$70.00</td>
<td>$56.7K</td>
<td>25.3K</td>
<td>12.5K</td>
</tr>
<tr>
<td>FLR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$55.00</td>
<td>$53.5K</td>
<td>6.0K</td>
<td>1.9K</td>
</tr>
<tr>
<td>AAL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/26/24</td>
<td>$11.00</td>
<td>$84.0K</td>
<td>17.2K</td>
<td>1.3K</td>
</tr>
<tr>
<td>SHLS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$8.00</td>
<td>$25.9K</td>
<td>487</td>
<td>833</td>
</tr>
<tr>
<td>PBI</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/16/24</td>
<td>$5.00</td>
<td>$33.3K</td>
<td>7.1K</td>
<td>100</td>
</tr>
<tr>
<td>BLDR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$165.00</td>
<td>$26.1K</td>
<td>844</td>
<td>52</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$180.00</td>
<td>$40.4K</td>
<td>432</td>
<td>41</td>
</tr>
<tr>
<td>CARR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$65.00</td>
<td>$412.5K</td>
<td>492</td>
<td>1</td>
</tr>
<tr>
<td>UNP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$210.00</td>
<td>$51.2K</td>
<td>135</td>
<td>0</td>
</tr>
<tr>
<td>GE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$90.00</td>
<td>$70.2K</td>
<td>1</td>
<td>0</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding UBER (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), we observe a call option trade with bullish sentiment. It expires in 2 day(s) on July 19, 2024. Parties traded 900 contract(s) at a $70.00 strike. The total cost received by the writing party (or parties) was $56.7K, with a price of $63.0 per contract. There were 25374 open contracts at this strike prior to today, and today 12599 contract(s) were bought and sold. 
• For FLR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>), we notice a call option sweep that happens to be bearish, expiring in 121 day(s) on November 15, 2024. This event was a transfer of 233 contract(s) at a $55.00 strike. This particular call needed to be split into 15 different trades to become filled. The total cost received by the writing party (or parties) was $53.5K, with a price of $230.0 per contract. There were 6095 open contracts at this strike prior to today, and today 1940 contract(s) were bought and sold. 
• Regarding AAL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>), we observe a put option sweep with bearish sentiment. It expires in 9 day(s) on July 26, 2024. Parties traded 2002 contract(s) at a $11.00 strike. This particular put needed to be split into 39 different trades to become filled. The total cost received by the writing party (or parties) was $84.0K, with a price of $42.0 per contract. There were 17238 open contracts at this strike prior to today, and today 1340 contract(s) were bought and sold. 
• Regarding SHLS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>), we observe a call option sweep with bullish sentiment. It expires in 30 day(s) on August 16, 2024. Parties traded 647 contract(s) at a $8.00 strike. This particular call needed to be split into 16 different trades to become filled. The total cost received by the writing party (or parties) was $25.9K, with a price of $40.0 per contract. There were 487 open contracts at this strike prior to today, and today 833 contract(s) were bought and sold. 
• For PBI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>), we notice a call option trade that happens to be neutral, expiring in 30 day(s) on August 16, 2024. This event was a transfer of 150 contract(s) at a $5.00 strike. The total cost received by the writing party (or parties) was $33.3K, with a price of $222.0 per contract. There were 7186 open contracts at this strike prior to today, and today 100 contract(s) were bought and sold. 
• Regarding BLDR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>), we observe a call option sweep with bullish sentiment. It expires in 30 day(s) on August 16, 2024. Parties traded 34 contract(s) at a $165.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $26.1K, with a price of $770.0 per contract. There were 844 open contracts at this strike prior to today, and today 52 contract(s) were bought and sold. 
• Regarding GEV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), we observe a call option trade with bullish sentiment. It expires in 184 day(s) on January 17, 2025. Parties traded 20 contract(s) at a $180.00 strike. The total cost received by the writing party (or parties) was $40.4K, with a price of $2020.0 per contract. There were 432 open contracts at this strike prior to today, and today 41 contract(s) were bought and sold. 
• For CARR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>), we notice a put option trade that happens to be bearish, expiring in 65 day(s) on September 20, 2024. This event was a transfer of 2500 contract(s) at a $65.00 strike. The total cost received by the writing party (or parties) was $412.5K, with a price of $165.0 per contract. There were 492 open contracts at this strike prior to today, and today 1 contract(s) were bought and sold. 
• Regarding UNP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>), we observe a put option trade with bullish sentiment. It expires in 548 day(s) on January 16, 2026. Parties traded 50 contract(s) at a $210.00 strike. The total cost received by the writing party (or parties) was $51.2K, with a price of $1025.0 per contract. There were 135 open contracts at this strike prior to today, and today 0 contract(s) were bought and sold. 
• Regarding GE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), we observe a call option trade with bearish sentiment. It expires in 184 day(s) on January 17, 2025. Parties traded 10 contract(s) at a $90.00 strike. The total cost received by the writing party (or parties) was $70.2K, with a price of $7024.0 per contract. There were 1 open contracts at this strike prior to today, and today 0 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

BLDR

CARR

SHLS

UBER

10 Industrials Stocks With Whale Alerts In Today's Session

Pitney Bowes Expects To Incur Charges Of ~$25M From Workforce Reduction Plan

Pitney Bowes Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) shares are trading higher after the company provided an update on the first phase of its cost rationalization initiative, initially <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39572500/pitney-bowes-provides-update-on-accelerated-progress-of-cost-rationalization-program-and-increases" rel="noreferrer noopener">announced in late May 2024</a>.
The company has identified and implemented around $70 million in cost savings, with most of these savings realized in the second quarter.
Pitney Bowes expects non-recurring charges of about $25 million related to these efforts to be recorded in the second quarter.
The cost reductions are expected to be mostly reflected in the company&#8217;s pre-tax earnings for the second half of 2024 and fully realized in 2025, primarily from expense reductions in SendTech and Presort.
Additionally, management has identified further opportunities to achieve efficiencies in the coming months, increasing the expected savings from an initial target of $60 million-$100 million to <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$120 million-$160 million</a>.
The company anticipates that a substantial portion of these additional savings will be realized by the end of 2024, while some initiatives will extend into 2025.
In May, Pitney Bowes reported a first-quarter loss per share of $0.01, beating estimates; revenues stand at<a target="_blank" href="https://www.benzinga.com/news/earnings/24/05/38589865/pitney-bowes-jumps-over-24-after-earnings-whats-going-on" rel="noreferrer noopener"> $830.509 million, surpassing expectations</a>.
At that time, the company said it expected FY24 revenue growth to be flat to a low-single-digit decline and stable EBIT margins.
Investors can gain exposure to the stock via Invesco Exchange-Traded Self-Indexed Fund Trust Invesco Russell 2000 Dynamic Multifactor ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/OMFS#BATS">OMFS</a>).
Price Action: PBI shares are up 13.6% at $5.77 at the last check Monday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Guidance

Small Cap

OMFS

Why Pitney Bowes Shares Are Shooting Higher today

Pitney Bowes shares are trading higher after the company announced an update on the first phase of its cost rationalization initiative.

Management has Expeditiously Implemented ~$70 Million in Cost Reductions Over the Past Month and Identified New Opportunities for Strengthening Pitney Bowes
The Cost Rationalization Program's Increased Savings Target is $120 Million to $160 Million, Up from $60 Million to $100 Million
Pitney Bowes Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) ("Pitney Bowes" or the "Company"), a global shipping and mailing company that provides technology, logistics and financial services, today announced an update on the first phase of the Company's cost rationalization initiative, which was previously announced in late May 2024.
The Company has identified and initiated approximately $70 million in cost savings, the majority of which has already been eliminated in the second quarter. Approximately $25 million of non-recurring charges associated with these efforts are expected to be recorded in the second quarter. The cost reductions announced today are anticipated to be largely reflected in the Company's second half of 2024 pre-tax earnings and fully reflected in 2025.

Management

Pitney Bowes Provides Update on Accelerated Progress of Cost Rationalization Program and Increases Savings Targets; Cost Rationalization Program's Increased Savings Target Is $120M-$160M, Up From $60M-$100M

Pitney Bowes Says New Process Is Commencing, As Process Run By Prior Board Did Not Result In Appointing Its Next Permanent CEO

Initial analysis has identified an additional&nbsp;$60 million&nbsp;to&nbsp;$100 million&nbsp;in potential annualized savings across the organization, apart from the Global Ecommerce business.&nbsp;Pitney Bowes is working to reduce its go-forward required cash needs by approximately&nbsp;$200 million.&nbsp;
In connection with these initiatives, Pitney Bowes has retained two nationally recognized consulting firms with financial and operational expertise.
&nbsp;

Pitney Bowes To Target Additional Annualized Cost Savings Of $60M-$100M, Balance Sheet, Cash Management Improvements To Expedite Paydown Of High-Cost Debt

Pitney Bowes Appoints Lance Rosenzweig As Interim CEO;  Jason Dies Has Stepped Down From Role Of Interim CEO And Retired From Company

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Thursday.
Shares of Nayax Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYAX#NASDAQ">NYAX</a>) fell sharply in today's pre-market trading following <a href="https://widgets.benzinga.com/quote/NYAX/earnings">weak quarterly results</a>.
Nayax posted a GAAP loss of 15 cents per share, compared to market expectations for a loss of 4 cents per share. The company's quarterly sales came in at $63.962 million, missing estimates of $72.825 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Nayax shares dipped 7.2% to $25.96 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Spire Global, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) shares dipped 23.3% to $8.70 in pre-market trading after the company reported mixed first-quarter financial results and lowered its FY24 forecast.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) shares declined 14.2% to $33.93 in pre-market trading after dipping around 19% on Wednesday.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) shares fell 10.5% to $4.90 in pre-market trading after tumbling 20% on Wednesday.</li>
<li>Pitney Bowes Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) shares declined 8.4% to $5.00 in pre-market trading. Pitney Bowes, earlier during the month, reported better-than-expected first-quarter EPS and sales.</li>
<li>Iris Energy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) shares declined 7.6% to $4.80 in pre-market trading after the company reported third-quarter results and filed for $500 million mixed securities shelf.</li>
<li>Ocugen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCGN#NASDAQ">OCGN</a>) shares declined 6.1% to $1.84 in pre-market trading following a 15% surge on Wednesday.</li>
<li>Dada Nexus Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) shares fell 5% to $1.91 in pre-market trading following weak quarterly results.</li>
<li>BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) shares declined 4.6% to $3.08 in pre-market trading after declining 7% on Wednesday.</li>
<li>New Oriental Education &amp; Technology Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) shares slipped 3.6% to $84.08 in pre-market trading.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38864592/walmart-deere-and-3-stocks-to-watch-heading-into-thursday">Walmart, Deere And 3 Stocks To Watch Heading Into Thursday</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

DADA

New Oriental Education & Technology Group

IREN

NYAX

OCGN

SPIR

Nayax Posts Weak Q1 Results, Joins GameStop, Iris Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Enovix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>) shares increased by 35.3% to $8.81 during Thursday's regular session. The market value of their outstanding shares is at $1.4 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Avis Budget Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) stock moved upwards by 23.26% to $116.79. The company's market cap stands at $4.1 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Pitney Bowes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) shares increased by 23.15% to $5.18. The market value of their outstanding shares is at $921.2 million. As per the press release, Q1 earnings came out today. </li>
<li>Nuburu (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BURU#AMEX">BURU</a>) stock increased by 18.43% to $0.21. The market value of their outstanding shares is at $7.8 million. </li>
<li>Valmont Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) shares increased by 16.97% to $242.95. The company's market cap stands at $4.9 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Howmet Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) stock increased by 15.36% to $77.04. The company's market cap stands at $31.4 billion. As per the news, the Q1 earnings report came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) shares decreased by 41.4% to $10.83 during Thursday's regular session. The market value of their outstanding shares is at $1.4 billion. As per the press release, Q2 earnings came out today. </li>
<li>Driven Brands Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRVN#NASDAQ">DRVN</a>) stock fell 25.99% to $10.85. The market value of their outstanding shares is at $1.7 billion. As per the press release, Q1 earnings came out today. </li>
<li>Energy Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERII#NASDAQ">ERII</a>) shares decreased by 13.49% to $12.68. The market value of their outstanding shares is at $726.6 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Professional Diversity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>) stock decreased by 13.15% to $1.52. The company's market cap stands at $17.4 million. </li>
<li>Enviri (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVRI#NYSE">NVRI</a>) stock declined by 13.04% to $7.07. The market value of their outstanding shares is at $564.4 million. As per the press release, Q1 earnings came out today. </li>
<li>Paycom Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>) stock declined by 12.82% to $162.37. The market value of their outstanding shares is at $9.4 billion. As per the news, the Q1 earnings report came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BURU

DRVN

ENVX

ERII

IPDN

NVRI

PAYC

VSTS

12 Industrials Stocks Moving In Thursday's Intraday Session

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pitney Bowes (NYSE:<a href="https://investorplace.com/stock-quotes/pbi-stock-quote/">PBI</a>) just reported results for the second quarter of 2024.<ul><li>Pitney Bowes reported earnings per share of 3 cents. This was above the analyst estimate for EPS of -7 cents.</li><li>The company reported revenue of $793.17 million.</li><li>This was 2.79% better than the analyst estimate for revenue of $771.65 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/pbi-stock-earnings-pitney-bowes-for-q2-of-2024/">PBI Stock Earnings: Pitney Bowes Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

PBI Stock Earnings: Pitney Bowes Beats EPS, Beats Revenue for Q2 2024

Pitney Bowes Inc. 2024 Q2 - Results - Earnings Call Presentation

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We have all of the biggest pre-market stock movers that traders need to know about on Friday morning!



Moving stocks this morning and more earnings reports, an acquisition deal, liquidation news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Iteris (NASDAQ:<a href="https://investorplace.com/stock-quotes/iti-stock-quote/">ITI</a>) stock is rocketing more than 62% <a href="https://www.nasdaq.com/press-release/iteris-be-acquired-almaviva-335-million-2024-08-09">alongside an acquisition deal</a>.</li>



<li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) shares are soaring over 61% on a <a href="https://www.nasdaq.com/press-release/nauticus-robotics-enters-aquanaut-mark-2-testing-partnership-fau-2024-08-08">new testing partnership</a>.</li>



<li>FSD Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/huge-stock-quote/">HUGE</a>) stock is surging more than 37% alongside heavy pre-market trading.</li>



<li>Bone Biologics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bblg-stock-quote/">BBLG</a>) shares are gaining over 30% with the <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318504957&amp;type=PDF&amp;symbol=BBLG&amp;cdn=81b72413280ee9face7494c21cc37055&amp;companyName=Bone+Biologics+Corp&amp;formType=ARS&amp;formDescription=Annual+Report+to+Security+Holders&amp;dateFiled=2024-08-08">release of its annual report</a>.</li>



<li>Pitney Bowes (NYSE:<a href="https://investorplace.com/stock-quotes/pbi-stock-quote/">PBI</a>) stock is rising more than 30% on plans to <a href="https://finance.yahoo.com/news/pitney-bowes-liquidate-ecommerce-unit-221312483.html">liquidate its e-commerce unit</a>.</li>



<li>Marin Software (NASDAQ:<a href="https://investorplace.com/stock-quotes/mrin-stock-quote/">MRIN</a>) shares are increasing over 28% after <a href="https://www.businesswire.com/news/home/20240808458407/en/Marin-Software-Extends-Reach-with-Reddit-and-X-Support">adding support for Reddit and X</a>, previously called Twitter.</li>



<li>Clearmind Medicine (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmnd-stock-quote/">CMND</a>) stock is heading more than 27% higher without any clear news this morning.</li>



<li>Doximity (NYSE:<a href="https://investorplace.com/stock-quotes/docs-stock-quote/">DOCS</a>) shares are climbing over 27% on a <a href="https://www.marketwatch.com/story/doximity-shares-rally-after-beating-1q-earnings-guidance-expectations-b9ce97d7?mod=markets">fiscal Q1 earnings beat</a>.</li>



<li>Satellogic (NASDAQ:<a href="https://investorplace.com/stock-quotes/satl-stock-quote/">SATL</a>) stock is jumping more than 26% today.</li>



<li>Babcock &amp; Wilcox (NYSE:<a href="https://investorplace.com/stock-quotes/bw-stock-quote/">BW</a>) shares are up over 25% after releasing its <a href="https://www.businesswire.com/news/home/20240808728017/en/Babcock-Wilcox-Enterprises-Reports-Second-Quarter-2024-Results-Earnings-Growth-Driven-By-Strong-Operating-Performance">Q2 earnings report</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>AN2 Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/antx-stock-quote/">ANTX</a>) stock is diving more than 33% <a href="https://www.nasdaq.com/press-release/an2-therapeutics-provides-update-ebo-301-phase-2-3-study-evaluating-epetraborole">with a clinical trial update</a>.</li>



<li>American Vanguard (NYSE:<a href="https://investorplace.com/stock-quotes/avd-stock-quote/">AVD</a>) shares are tumbling over 29% with the <a href="https://www.nasdaq.com/press-release/american-vanguard-reports-q2-2024-results-2024-08-08">release of its latest earnings report</a>.</li>



<li>PubMatic (NASDAQ:<a href="https://investorplace.com/stock-quotes/pubm-stock-quote/">PUBM</a>) stock is taking a more than 27% beating on <a href="https://www.stocktitan.net/news/PUBM/pub-matic-announces-second-quarter-2024-financial-zmrbbq0dmfh8.html">missed Q2 revenue</a>.</li>



<li>Eventbrite (NYSE:<a href="https://investorplace.com/stock-quotes/eb-stock-quote/">EB</a>) shares are sliding over 23% alongside <a href="https://www.tipranks.com/news/company-announcements/eventbrite-announces-layoffs-and-welcomes-new-coo-cfo">layoffs and leadership changes</a>.</li>



<li>Beauty Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/skin-stock-quote/">SKIN</a>) stock is decreasing more than 22% after <a href="https://www.nasdaq.com/press-release/beautyhealth-reports-second-quarter-2024-financial-results-2024-08-08">posting its Q2 earnings report</a>.</li>



<li>Cutera (NASDAQ:<a href="https://investorplace.com/stock-quotes/cutr-stock-quote/">CUTR</a>) shares are dropping over 21% with its <a href="https://www.nasdaq.com/press-release/cuterar-announces-second-quarter-2024-financial-results-2024-08-08">latest earnings news</a>.</li>



<li>Microvast (NASDAQ:<a href="https://investorplace.com/stock-quotes/mvst-stock-quote/">MVST</a>) stock is falling more than 19% after releasing its <a href="https://ir.microvast.com/static-files/b376f438-a4e5-4a1a-ac22-a6107e450b24">Q2 2024 earnings</a>.</li>



<li>FiscalNote (NYSE:<a href="https://investorplace.com/stock-quotes/note-stock-quote/">NOTE</a>) shares are slipping over 18% after <a href="https://finance.yahoo.com/news/fiscalnote-holdings-inc-note-reports-231505554.html">posting a Q2 loss</a>.</li>



<li>Nerdy (NYSE:<a href="https://investorplace.com/stock-quotes/nrdy-stock-quote/">NRDY</a>) stock is dipping more than 18% after <a href="https://www.nasdaq.com/press-release/nerdy-announces-second-quarter-2024-financial-results-2024-08-08">releasing its Q2 earnings report</a>.</li>



<li>Five9 (NASDAQ:<a href="https://investorplace.com/stock-quotes/fivn-stock-quote/">FIVN</a>) shares close out our pre-market stock movers down over 15% with its <a href="https://www.nasdaq.com/press-release/five9-surpasses-1-billion-annual-revenue-run-rate-2024-08-08">most recent earnings report</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-aug-9th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Pitney Bowes Inc. (PBI) Q2 2024 Earnings Call Transcript

Pitney Bowes Culls Global E-Commerce And Shape-Shifts Under Kurt Wolf

Pitney Bowes (PBI) just unveiled an announcement. John Witek has been appointed as the new Chief Accounting Officer of the company, taking over fro...

Pitney Bowes Appoints John Witek as Chief Accounting Officer

Small-cap stocks have climbed recently. Here are the ones most poised for further upside

Buying More Pitney Bowes

Pitney Bowes: Margin Tailwinds Are A Temporary Catalyst

MSA Safety: The Safe Move Here Is A Downgrade

ANTX

AQST

BBLG

BFLY

BYRN

CDNA

CLOV

CMND

COMM

CURI

CUTR

DAVE

DOCS

ESOA

EVER

FIVN

GTHX

HRTG

HUGE

HYLN

INSG

JAGGF

KITT

MLKN

MNESP

MRIN

MVST

NOTE

NRDY

OPFI

PRAX

PSIX

PSNL

PUBM

SATL

SKIN

SUPV

TILE

USAP

Press Releases

Pitney Bowes Announces Leadership Transition and New Initiatives to Accelerate Value Creation

Pitney Bowes to Host Investor Conference Call

Pitney Bowes Opens New Presort Services Operating Center Serving St. Louis Market

Pitney Bowes Provides Update on Accelerated Progress of Cost Rationalization Program and Increases Savings Targets

Pitney Bowes Announces Leadership Transition in Global Ecommerce Segment

Pitney Bowes Announces Date for Second Quarter 2024 Earnings Release and Conference Call

Pitney Bowes Announces Value-Maximizing Exit Path for Global Ecommerce Segment

Pitney Bowes Announces Financial Results for Second Quarter of Fiscal Year 2024 and Provides a Progress Update on Strategic Initiatives

Pitney Bowes Declares Common Stock Dividend

Pitney Bowes Enhances Ecommerce Shipping with ShipAccel

Comments

Pitney Bowes

Vendite allo scoperto

Pitney Bowes (NYSE:PBI) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO